A&D Pharma turns a profit in 2009 after loss in 2008

Newsroom 22/03/2010 | 11:17

Pharmaceutical company A&D Pharma posted a EUR 19 million profit last year, after seeing losses of EUR 2.3 million the year before, the company has announced. Its turnover went up by just 3 percent, to EUR 514 million. The turnover growth reported in Romanian currency was however 18 percent, according to the company’s unaudited financial results.

The firm’s operational profit went up by 166 percent, to EUR 35 million, from EUR 13.2 million in 2008. A&D Pharma’s net debt rose from EUR 35.4 million in 2008 to EUR 61.8 million last year.

A&D Pharma restructured its business last year in order to reduce costs. Mediplus, the distribution division of A&D Pharma, saw its revenues rise 16 percent, to EUR 380 million, while its operational profit was EUR 28.3 million. The retail division Sensiblu, which runs pharmacies under the same brand, upped its revenues by 23 percent to EUR 190.8 million and started making a profit, said Robert Popescu, CEO of A&D Pharma. He sees significant growth opportunities for the holding on Central and Eastern European markets.

Corina Saceanu

 

BR Magazine | Latest Issue

Download PDF or read online: November 2022 Issue | Business Review Magazine

The November 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Samsung Remains Top Consumer Tech Provider on Romanian Market.” Read
Newsroom | 29/11/2022 | 10:17

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu
    I agree with the storage and handling of my data by business-review.eu
    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue